Report banner
Home
Industries
Healthcare
Parkinson’s Disease Therapeutics Market
Updated On

Jan 28 2025

Total Pages

150

Market
Insights

7,500+

Reports delivered globally, covering a wide range of industries and sectors.

2,350+

Clients who trust our expertise and rely on our insights for business decisions.

1,050+

Managed Reports, ensuring seamless updates and premium service.

100%

Satisfied Customers, committed to delivering exceptional value and quality.

Parkinson’s Disease Therapeutics Market 2025-2033 Overview: Trends, Dynamics, and Growth Opportunities

Parkinson’s Disease Therapeutics Market by Drug Class (Levodopa/Carbidopa, Dopamine Agonist, Adenosine A2A Antagonist, COMT Inhibitors, MAO-B Inhibitors, Glutamate Antagonist, Others), by Route of Administration (Oral, Subcutaneous, Transdermal, Others), by Patient (Adult, Pediatric), by North America (U.S., Canada), by Europe (Germany, UK, France, Spain, Italy), by Asia Pacific (Japan, China, India, South Korea, Australia), by Latin America (Brazil, Mexico, Argentina), by Middle East & Africa (South Africa, Saudi Arabia) Forecast 2025-2033

Main Logo

Parkinson’s Disease Therapeutics Market 2025-2033 Overview: Trends, Dynamics, and Growth Opportunities

Key Insights

The size of the Parkinson’s Disease Therapeutics Market market was valued at USD 5,182.3 Million in 2024 and is projected to reach USD XXX Million by 2033, with an expected CAGR of 6.5% during the forecast period. The Parkinson's Disease Therapeutics Market is growing highly, mainly because of the ever-increasing cases of Parkinson's disease in the world. The main factor is the age-related increase. Parkinson's disease is a neurodegenerative disorder that seriously impacts motor activity. Thus, it is a condition where patients require symptomatic treatment instead of a cure. The market leaders in this area are dopamine agonists, MAO-B inhibitors, and levodopa-based drugs. The demand for novel treatments is leading to the pursuit of research into gene therapy and neuroprotective drugs to inhibit the progression of the disease. Advanced drug delivery systems such as transdermal patches and inhalable formulations are also improving patient compliance.
Funding for Parkinson's research is on the rise, and this supports the development of novel therapeutic agents. However, key issues remain: expensive treatment, side effects caused by continuous drug intake, and limited accessibility of advanced therapies in the majority of developing regions. Despite these issues, the direction of using AI in drug discovery and personalized medicine approaches is considered to be a promising trend. Partnerships, by pharmaceutical companies and research institutions, accelerate the pipeline of potential therapies. With growing awareness, the promise of technological advancements in advancing the Parkinson's Disease Therapeutics Market towards significant transformation is at hand, improving the quality of life for millions of patients worldwide.

Parkinson’s Disease Therapeutics Market Research Report - Market Size, Growth & Forecast

Parkinson’s Disease Therapeutics Market Concentration & Characteristics

The Parkinson's Disease Therapeutics Market is highly concentrated, with the top five players accounting for over 60% of the market share. The market is characterized by a number of factors, including:

  • Innovation: The market is driven by innovation, with new drugs and therapies being developed all the time. This innovation is necessary to meet the evolving needs of patients with Parkinson's disease.
  • Impact of regulations: The market is heavily regulated, with new drugs and therapies requiring approval from regulatory agencies before they can be marketed. This regulation is necessary to ensure the safety and efficacy of new treatments.
  • Product substitutes: There are a number of different drugs and therapies available to treat Parkinson's disease. This competition can limit the pricing power of individual manufacturers.
  • End user concentration: The market is concentrated among a small number of end users, including hospitals, clinics, and nursing homes. This concentration can give these end users significant bargaining power.
  • M&A activity: There has been a significant amount of M&A activity in the Parkinson's Disease Therapeutics Market in recent years. This activity is driven by the desire to gain market share and access to new technologies.

Parkinson’s Disease Therapeutics Market Trends

The Parkinson's Disease Therapeutics Market is experiencing a number of trends, including:

  • Growing demand for new therapies: The increasing prevalence of Parkinson's disease is leading to a growing demand for new and effective therapies. This demand is expected to continue to grow in the coming years.
  • Focus on patient-centered care: The market is moving towards a more patient-centered approach. This approach focuses on the needs of individual patients and their families.
  • Rise of personalized medicine: The market is also seeing a rise in personalized medicine. This approach involves tailoring treatment to the individual patient's genetic and biological profile.
  • Advancements in technology: Advancements in technology are leading to the development of new and more effective therapies. These advancements include the use of artificial intelligence, machine learning, and gene therapy.

Parkinson’s Disease Therapeutics Market Growth

Key Region or Country & Segment to Dominate the Market

The North American market is the largest market for Parkinson's disease therapeutics, accounting for over 40% of the global market share. This is due to the high prevalence of Parkinson's disease in the region and the availability of a wide range of therapies. The Asia Pacific market is expected to grow at the fastest rate over the forecast period. This growth is due to the increasing prevalence of Parkinson's disease in the region and the growing demand for effective therapies.

Parkinson’s Disease Therapeutics Market Product Insights Report Coverage & Deliverables

The Parkinson's Disease Therapeutics Market product insights report coverage and deliverables include:

  • Market size and forecast: The report provides a detailed analysis of the market size and forecast for the Parkinson's Disease Therapeutics Market.
  • Market share analysis: The report provides an analysis of the market share of the major players in the Parkinson's Disease Therapeutics Market.
  • Product analysis: The report provides a detailed analysis of the products available in the Parkinson's Disease Therapeutics Market.
  • Competitive landscape: The report provides a detailed analysis of the competitive landscape of the Parkinson's Disease Therapeutics Market.
  • Key market trends: The report provides an analysis of the key market trends in the Parkinson's Disease Therapeutics Market.
  • Market opportunities: The report provides an analysis of the market opportunities in the Parkinson's Disease Therapeutics Market.

Parkinson’s Disease Therapeutics Market Analysis

The Parkinson's Disease Therapeutics Market is expected to grow at a CAGR of 6.5% over the forecast period. This growth is driven by a number of factors, including the rising prevalence of

Parkinson’s Disease Therapeutics Drivers

  • Advancements in Personalized Medicine: Personalized treatments are enabling tailored therapies based on genetic and molecular profiling, improving the efficacy of Parkinson's treatments.
  • Growing Patient Population: The rising number of Parkinson's Disease patients, due to the aging global population, is driving increased demand for novel therapies.
  • Increased Research Investment: Significant funding and research by both private and public sectors are accelerating the development of innovative treatment options.

Parkinson’s Disease Therapeutics Market Challenges

  • Disease Complexity: Parkinson's Disease has diverse symptoms and varying progression, making it difficult to find one-size-fits-all treatments.
  • Lack of Disease-Modifying Therapies: There are few treatments that slow or stop the disease progression, focusing mainly on symptom management.
  • High R&D Costs and Regulatory Hurdles: Developing new therapies involves long timelines and high costs due to stringent clinical trial and regulatory approval processes.

Parkinson’s Disease Therapeutics Market Emerging Trends

  • Gene Therapy: The use of gene-editing techniques such as CRISPR for potential cures by modifying genetic factors responsible for Parkinson's Disease is gaining traction.
  • Neurostimulation Devices: Advancements in deep brain stimulation and wearable neurostimulation devices are emerging as non-invasive therapies to manage symptoms.
  • Biomarker Development: The identification of biomarkers for early detection and monitoring of disease progression is a key area of focus, enabling more accurate diagnosis and targeted treatments.

Parkinson’s Disease Therapeutics Market Key Players

  • AbbVie
  • Acorda Therapeutics
  • Cerevel Therapeutics
  • Intra-Cellular Therapies
  • Prothena Corporation
  • Neurolixis
  • Lario Therapeutics
  • Prevail Therapeutics
  • BrainStorm Cell Therapeutics
  • CureMetrix
  • CureApp
  • CureMetrix
  • CureApp
  • CureMetrix
  • CureApp

Parkinson’s Disease Therapeutics Market Segmentation

  • 1. Drug Class
    • 1.1. Levodopa/Carbidopa
    • 1.2. Dopamine Agonist
    • 1.3. Adenosine A2A Antagonist
    • 1.4. COMT Inhibitors
    • 1.5. MAO-B Inhibitors
    • 1.6. Glutamate Antagonist
    • 1.7. Others
  • 2. Route of Administration
    • 2.1. Oral
    • 2.2. Subcutaneous
    • 2.3. Transdermal
    • 2.4. Others
  • 3. Patient
    • 3.1. Adult
    • 3.2. Pediatric

Parkinson’s Disease Therapeutics Market Segmentation By Geography

  • 1. North America
    • 1.1. U.S.
    • 1.2. Canada
  • 2. Europe
    • 2.1. Germany
    • 2.2. UK
    • 2.3. France
    • 2.4. Spain
    • 2.5. Italy
  • 3. Asia Pacific
    • 3.1. Japan
    • 3.2. China
    • 3.3. India
    • 3.4. South Korea
    • 3.5. Australia
  • 4. Latin America
    • 4.1. Brazil
    • 4.2. Mexico
    • 4.3. Argentina
  • 5. Middle East & Africa
    • 5.1. South Africa
    • 5.2. Saudi Arabia

Parkinson’s Disease Therapeutics Market Regional Share

Parkinson’s Disease Therapeutics Market REPORT HIGHLIGHTS

AspectsDetails
Study Period 2019-2033
Base Year 2024
Estimated Year 2025
Forecast Period2025-2033
Historical Period2019-2024
Growth RateCAGR of 6.5% from 2019-2033
Segmentation
    • By Drug Class
      • Levodopa/Carbidopa
      • Dopamine Agonist
      • Adenosine A2A Antagonist
      • COMT Inhibitors
      • MAO-B Inhibitors
      • Glutamate Antagonist
      • Others
    • By Route of Administration
      • Oral
      • Subcutaneous
      • Transdermal
      • Others
    • By Patient
      • Adult
      • Pediatric
  • By Geography
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • UK
      • France
      • Spain
      • Italy
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Australia
    • Latin America
      • Brazil
      • Mexico
      • Argentina
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
Table Of Content
  1. 1. Introduction
    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions
  2. 2. Executive Summary
    • 2.1. Introduction
  3. 3. Market Dynamics
    • 3.1. Introduction
      • 3.2. Market Drivers
        • 3.2.1 Growing aging population coupled with increasing prevalence of Parkinson’s disease
        • 3.2.2 Increasing number of drug approvals
        • 3.2.3 Growing awareness among the population
        • 3.2.4 Growing funding in R&D
      • 3.3. Market Restrains
        • 3.3.1. High cost of the treatment
      • 3.4. Market Trends
  4. 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  5. 5. Global Parkinson’s Disease Therapeutics Market Analysis, Insights and Forecast, 2019-2031
    • 5.1. Market Analysis, Insights and Forecast - by Drug Class
      • 5.1.1. Levodopa/Carbidopa
      • 5.1.2. Dopamine Agonist
      • 5.1.3. Adenosine A2A Antagonist
      • 5.1.4. COMT Inhibitors
      • 5.1.5. MAO-B Inhibitors
      • 5.1.6. Glutamate Antagonist
      • 5.1.7. Others
    • 5.2. Market Analysis, Insights and Forecast - by Route of Administration
      • 5.2.1. Oral
      • 5.2.2. Subcutaneous
      • 5.2.3. Transdermal
      • 5.2.4. Others
    • 5.3. Market Analysis, Insights and Forecast - by Patient
      • 5.3.1. Adult
      • 5.3.2. Pediatric
    • 5.4. Market Analysis, Insights and Forecast - by Region
      • 5.4.1. North America
      • 5.4.2. Europe
      • 5.4.3. Asia Pacific
      • 5.4.4. Latin America
      • 5.4.5. Middle East & Africa
  6. 6. North America Parkinson’s Disease Therapeutics Market Analysis, Insights and Forecast, 2019-2031
    • 6.1. Market Analysis, Insights and Forecast - by Drug Class
      • 6.1.1. Levodopa/Carbidopa
      • 6.1.2. Dopamine Agonist
      • 6.1.3. Adenosine A2A Antagonist
      • 6.1.4. COMT Inhibitors
      • 6.1.5. MAO-B Inhibitors
      • 6.1.6. Glutamate Antagonist
      • 6.1.7. Others
    • 6.2. Market Analysis, Insights and Forecast - by Route of Administration
      • 6.2.1. Oral
      • 6.2.2. Subcutaneous
      • 6.2.3. Transdermal
      • 6.2.4. Others
    • 6.3. Market Analysis, Insights and Forecast - by Patient
      • 6.3.1. Adult
      • 6.3.2. Pediatric
  7. 7. Europe Parkinson’s Disease Therapeutics Market Analysis, Insights and Forecast, 2019-2031
    • 7.1. Market Analysis, Insights and Forecast - by Drug Class
      • 7.1.1. Levodopa/Carbidopa
      • 7.1.2. Dopamine Agonist
      • 7.1.3. Adenosine A2A Antagonist
      • 7.1.4. COMT Inhibitors
      • 7.1.5. MAO-B Inhibitors
      • 7.1.6. Glutamate Antagonist
      • 7.1.7. Others
    • 7.2. Market Analysis, Insights and Forecast - by Route of Administration
      • 7.2.1. Oral
      • 7.2.2. Subcutaneous
      • 7.2.3. Transdermal
      • 7.2.4. Others
    • 7.3. Market Analysis, Insights and Forecast - by Patient
      • 7.3.1. Adult
      • 7.3.2. Pediatric
  8. 8. Asia Pacific Parkinson’s Disease Therapeutics Market Analysis, Insights and Forecast, 2019-2031
    • 8.1. Market Analysis, Insights and Forecast - by Drug Class
      • 8.1.1. Levodopa/Carbidopa
      • 8.1.2. Dopamine Agonist
      • 8.1.3. Adenosine A2A Antagonist
      • 8.1.4. COMT Inhibitors
      • 8.1.5. MAO-B Inhibitors
      • 8.1.6. Glutamate Antagonist
      • 8.1.7. Others
    • 8.2. Market Analysis, Insights and Forecast - by Route of Administration
      • 8.2.1. Oral
      • 8.2.2. Subcutaneous
      • 8.2.3. Transdermal
      • 8.2.4. Others
    • 8.3. Market Analysis, Insights and Forecast - by Patient
      • 8.3.1. Adult
      • 8.3.2. Pediatric
  9. 9. Latin America Parkinson’s Disease Therapeutics Market Analysis, Insights and Forecast, 2019-2031
    • 9.1. Market Analysis, Insights and Forecast - by Drug Class
      • 9.1.1. Levodopa/Carbidopa
      • 9.1.2. Dopamine Agonist
      • 9.1.3. Adenosine A2A Antagonist
      • 9.1.4. COMT Inhibitors
      • 9.1.5. MAO-B Inhibitors
      • 9.1.6. Glutamate Antagonist
      • 9.1.7. Others
    • 9.2. Market Analysis, Insights and Forecast - by Route of Administration
      • 9.2.1. Oral
      • 9.2.2. Subcutaneous
      • 9.2.3. Transdermal
      • 9.2.4. Others
    • 9.3. Market Analysis, Insights and Forecast - by Patient
      • 9.3.1. Adult
      • 9.3.2. Pediatric
  10. 10. Middle East & Africa Parkinson’s Disease Therapeutics Market Analysis, Insights and Forecast, 2019-2031
    • 10.1. Market Analysis, Insights and Forecast - by Drug Class
      • 10.1.1. Levodopa/Carbidopa
      • 10.1.2. Dopamine Agonist
      • 10.1.3. Adenosine A2A Antagonist
      • 10.1.4. COMT Inhibitors
      • 10.1.5. MAO-B Inhibitors
      • 10.1.6. Glutamate Antagonist
      • 10.1.7. Others
    • 10.2. Market Analysis, Insights and Forecast - by Route of Administration
      • 10.2.1. Oral
      • 10.2.2. Subcutaneous
      • 10.2.3. Transdermal
      • 10.2.4. Others
    • 10.3. Market Analysis, Insights and Forecast - by Patient
      • 10.3.1. Adult
      • 10.3.2. Pediatric
  11. 11. Competitive Analysis
    • 11.1. Global Market Share Analysis 2024
      • 11.2. Company Profiles
        • 11.2.1 Orion Corporation
          • 11.2.1.1. Overview
          • 11.2.1.2. Products
          • 11.2.1.3. SWOT Analysis
          • 11.2.1.4. Recent Developments
          • 11.2.1.5. Financials (Based on Availability)
        • 11.2.2 Roche
          • 11.2.2.1. Overview
          • 11.2.2.2. Products
          • 11.2.2.3. SWOT Analysis
          • 11.2.2.4. Recent Developments
          • 11.2.2.5. Financials (Based on Availability)
        • 11.2.3 AbbVie Inc.
          • 11.2.3.1. Overview
          • 11.2.3.2. Products
          • 11.2.3.3. SWOT Analysis
          • 11.2.3.4. Recent Developments
          • 11.2.3.5. Financials (Based on Availability)
        • 11.2.4 Acadia Pharmaceuticals
          • 11.2.4.1. Overview
          • 11.2.4.2. Products
          • 11.2.4.3. SWOT Analysis
          • 11.2.4.4. Recent Developments
          • 11.2.4.5. Financials (Based on Availability)
        • 11.2.5 Amneal Pharmaceuticals
          • 11.2.5.1. Overview
          • 11.2.5.2. Products
          • 11.2.5.3. SWOT Analysis
          • 11.2.5.4. Recent Developments
          • 11.2.5.5. Financials (Based on Availability)
        • 11.2.6 UCB
          • 11.2.6.1. Overview
          • 11.2.6.2. Products
          • 11.2.6.3. SWOT Analysis
          • 11.2.6.4. Recent Developments
          • 11.2.6.5. Financials (Based on Availability)
        • 11.2.7 Teva Pharmaceutical
          • 11.2.7.1. Overview
          • 11.2.7.2. Products
          • 11.2.7.3. SWOT Analysis
          • 11.2.7.4. Recent Developments
          • 11.2.7.5. Financials (Based on Availability)
List of Figures
  1. Figure 1: Global Parkinson’s Disease Therapeutics Market Revenue Breakdown (Million, %) by Region 2024 & 2032
  2. Figure 2: Global Parkinson’s Disease Therapeutics Market Volume Breakdown (K Tons, %) by Region 2024 & 2032
  3. Figure 3: North America Parkinson’s Disease Therapeutics Market Revenue (Million), by Drug Class 2024 & 2032
  4. Figure 4: North America Parkinson’s Disease Therapeutics Market Volume (K Tons), by Drug Class 2024 & 2032
  5. Figure 5: North America Parkinson’s Disease Therapeutics Market Revenue Share (%), by Drug Class 2024 & 2032
  6. Figure 6: North America Parkinson’s Disease Therapeutics Market Volume Share (%), by Drug Class 2024 & 2032
  7. Figure 7: North America Parkinson’s Disease Therapeutics Market Revenue (Million), by Route of Administration 2024 & 2032
  8. Figure 8: North America Parkinson’s Disease Therapeutics Market Volume (K Tons), by Route of Administration 2024 & 2032
  9. Figure 9: North America Parkinson’s Disease Therapeutics Market Revenue Share (%), by Route of Administration 2024 & 2032
  10. Figure 10: North America Parkinson’s Disease Therapeutics Market Volume Share (%), by Route of Administration 2024 & 2032
  11. Figure 11: North America Parkinson’s Disease Therapeutics Market Revenue (Million), by Patient 2024 & 2032
  12. Figure 12: North America Parkinson’s Disease Therapeutics Market Volume (K Tons), by Patient 2024 & 2032
  13. Figure 13: North America Parkinson’s Disease Therapeutics Market Revenue Share (%), by Patient 2024 & 2032
  14. Figure 14: North America Parkinson’s Disease Therapeutics Market Volume Share (%), by Patient 2024 & 2032
  15. Figure 15: North America Parkinson’s Disease Therapeutics Market Revenue (Million), by Country 2024 & 2032
  16. Figure 16: North America Parkinson’s Disease Therapeutics Market Volume (K Tons), by Country 2024 & 2032
  17. Figure 17: North America Parkinson’s Disease Therapeutics Market Revenue Share (%), by Country 2024 & 2032
  18. Figure 18: North America Parkinson’s Disease Therapeutics Market Volume Share (%), by Country 2024 & 2032
  19. Figure 19: Europe Parkinson’s Disease Therapeutics Market Revenue (Million), by Drug Class 2024 & 2032
  20. Figure 20: Europe Parkinson’s Disease Therapeutics Market Volume (K Tons), by Drug Class 2024 & 2032
  21. Figure 21: Europe Parkinson’s Disease Therapeutics Market Revenue Share (%), by Drug Class 2024 & 2032
  22. Figure 22: Europe Parkinson’s Disease Therapeutics Market Volume Share (%), by Drug Class 2024 & 2032
  23. Figure 23: Europe Parkinson’s Disease Therapeutics Market Revenue (Million), by Route of Administration 2024 & 2032
  24. Figure 24: Europe Parkinson’s Disease Therapeutics Market Volume (K Tons), by Route of Administration 2024 & 2032
  25. Figure 25: Europe Parkinson’s Disease Therapeutics Market Revenue Share (%), by Route of Administration 2024 & 2032
  26. Figure 26: Europe Parkinson’s Disease Therapeutics Market Volume Share (%), by Route of Administration 2024 & 2032
  27. Figure 27: Europe Parkinson’s Disease Therapeutics Market Revenue (Million), by Patient 2024 & 2032
  28. Figure 28: Europe Parkinson’s Disease Therapeutics Market Volume (K Tons), by Patient 2024 & 2032
  29. Figure 29: Europe Parkinson’s Disease Therapeutics Market Revenue Share (%), by Patient 2024 & 2032
  30. Figure 30: Europe Parkinson’s Disease Therapeutics Market Volume Share (%), by Patient 2024 & 2032
  31. Figure 31: Europe Parkinson’s Disease Therapeutics Market Revenue (Million), by Country 2024 & 2032
  32. Figure 32: Europe Parkinson’s Disease Therapeutics Market Volume (K Tons), by Country 2024 & 2032
  33. Figure 33: Europe Parkinson’s Disease Therapeutics Market Revenue Share (%), by Country 2024 & 2032
  34. Figure 34: Europe Parkinson’s Disease Therapeutics Market Volume Share (%), by Country 2024 & 2032
  35. Figure 35: Asia Pacific Parkinson’s Disease Therapeutics Market Revenue (Million), by Drug Class 2024 & 2032
  36. Figure 36: Asia Pacific Parkinson’s Disease Therapeutics Market Volume (K Tons), by Drug Class 2024 & 2032
  37. Figure 37: Asia Pacific Parkinson’s Disease Therapeutics Market Revenue Share (%), by Drug Class 2024 & 2032
  38. Figure 38: Asia Pacific Parkinson’s Disease Therapeutics Market Volume Share (%), by Drug Class 2024 & 2032
  39. Figure 39: Asia Pacific Parkinson’s Disease Therapeutics Market Revenue (Million), by Route of Administration 2024 & 2032
  40. Figure 40: Asia Pacific Parkinson’s Disease Therapeutics Market Volume (K Tons), by Route of Administration 2024 & 2032
  41. Figure 41: Asia Pacific Parkinson’s Disease Therapeutics Market Revenue Share (%), by Route of Administration 2024 & 2032
  42. Figure 42: Asia Pacific Parkinson’s Disease Therapeutics Market Volume Share (%), by Route of Administration 2024 & 2032
  43. Figure 43: Asia Pacific Parkinson’s Disease Therapeutics Market Revenue (Million), by Patient 2024 & 2032
  44. Figure 44: Asia Pacific Parkinson’s Disease Therapeutics Market Volume (K Tons), by Patient 2024 & 2032
  45. Figure 45: Asia Pacific Parkinson’s Disease Therapeutics Market Revenue Share (%), by Patient 2024 & 2032
  46. Figure 46: Asia Pacific Parkinson’s Disease Therapeutics Market Volume Share (%), by Patient 2024 & 2032
  47. Figure 47: Asia Pacific Parkinson’s Disease Therapeutics Market Revenue (Million), by Country 2024 & 2032
  48. Figure 48: Asia Pacific Parkinson’s Disease Therapeutics Market Volume (K Tons), by Country 2024 & 2032
  49. Figure 49: Asia Pacific Parkinson’s Disease Therapeutics Market Revenue Share (%), by Country 2024 & 2032
  50. Figure 50: Asia Pacific Parkinson’s Disease Therapeutics Market Volume Share (%), by Country 2024 & 2032
  51. Figure 51: Latin America Parkinson’s Disease Therapeutics Market Revenue (Million), by Drug Class 2024 & 2032
  52. Figure 52: Latin America Parkinson’s Disease Therapeutics Market Volume (K Tons), by Drug Class 2024 & 2032
  53. Figure 53: Latin America Parkinson’s Disease Therapeutics Market Revenue Share (%), by Drug Class 2024 & 2032
  54. Figure 54: Latin America Parkinson’s Disease Therapeutics Market Volume Share (%), by Drug Class 2024 & 2032
  55. Figure 55: Latin America Parkinson’s Disease Therapeutics Market Revenue (Million), by Route of Administration 2024 & 2032
  56. Figure 56: Latin America Parkinson’s Disease Therapeutics Market Volume (K Tons), by Route of Administration 2024 & 2032
  57. Figure 57: Latin America Parkinson’s Disease Therapeutics Market Revenue Share (%), by Route of Administration 2024 & 2032
  58. Figure 58: Latin America Parkinson’s Disease Therapeutics Market Volume Share (%), by Route of Administration 2024 & 2032
  59. Figure 59: Latin America Parkinson’s Disease Therapeutics Market Revenue (Million), by Patient 2024 & 2032
  60. Figure 60: Latin America Parkinson’s Disease Therapeutics Market Volume (K Tons), by Patient 2024 & 2032
  61. Figure 61: Latin America Parkinson’s Disease Therapeutics Market Revenue Share (%), by Patient 2024 & 2032
  62. Figure 62: Latin America Parkinson’s Disease Therapeutics Market Volume Share (%), by Patient 2024 & 2032
  63. Figure 63: Latin America Parkinson’s Disease Therapeutics Market Revenue (Million), by Country 2024 & 2032
  64. Figure 64: Latin America Parkinson’s Disease Therapeutics Market Volume (K Tons), by Country 2024 & 2032
  65. Figure 65: Latin America Parkinson’s Disease Therapeutics Market Revenue Share (%), by Country 2024 & 2032
  66. Figure 66: Latin America Parkinson’s Disease Therapeutics Market Volume Share (%), by Country 2024 & 2032
  67. Figure 67: Middle East & Africa Parkinson’s Disease Therapeutics Market Revenue (Million), by Drug Class 2024 & 2032
  68. Figure 68: Middle East & Africa Parkinson’s Disease Therapeutics Market Volume (K Tons), by Drug Class 2024 & 2032
  69. Figure 69: Middle East & Africa Parkinson’s Disease Therapeutics Market Revenue Share (%), by Drug Class 2024 & 2032
  70. Figure 70: Middle East & Africa Parkinson’s Disease Therapeutics Market Volume Share (%), by Drug Class 2024 & 2032
  71. Figure 71: Middle East & Africa Parkinson’s Disease Therapeutics Market Revenue (Million), by Route of Administration 2024 & 2032
  72. Figure 72: Middle East & Africa Parkinson’s Disease Therapeutics Market Volume (K Tons), by Route of Administration 2024 & 2032
  73. Figure 73: Middle East & Africa Parkinson’s Disease Therapeutics Market Revenue Share (%), by Route of Administration 2024 & 2032
  74. Figure 74: Middle East & Africa Parkinson’s Disease Therapeutics Market Volume Share (%), by Route of Administration 2024 & 2032
  75. Figure 75: Middle East & Africa Parkinson’s Disease Therapeutics Market Revenue (Million), by Patient 2024 & 2032
  76. Figure 76: Middle East & Africa Parkinson’s Disease Therapeutics Market Volume (K Tons), by Patient 2024 & 2032
  77. Figure 77: Middle East & Africa Parkinson’s Disease Therapeutics Market Revenue Share (%), by Patient 2024 & 2032
  78. Figure 78: Middle East & Africa Parkinson’s Disease Therapeutics Market Volume Share (%), by Patient 2024 & 2032
  79. Figure 79: Middle East & Africa Parkinson’s Disease Therapeutics Market Revenue (Million), by Country 2024 & 2032
  80. Figure 80: Middle East & Africa Parkinson’s Disease Therapeutics Market Volume (K Tons), by Country 2024 & 2032
  81. Figure 81: Middle East & Africa Parkinson’s Disease Therapeutics Market Revenue Share (%), by Country 2024 & 2032
  82. Figure 82: Middle East & Africa Parkinson’s Disease Therapeutics Market Volume Share (%), by Country 2024 & 2032
List of Tables
  1. Table 1: Global Parkinson’s Disease Therapeutics Market Revenue Million Forecast, by Region 2019 & 2032
  2. Table 2: Global Parkinson’s Disease Therapeutics Market Volume K Tons Forecast, by Region 2019 & 2032
  3. Table 3: Global Parkinson’s Disease Therapeutics Market Revenue Million Forecast, by Drug Class 2019 & 2032
  4. Table 4: Global Parkinson’s Disease Therapeutics Market Volume K Tons Forecast, by Drug Class 2019 & 2032
  5. Table 5: Global Parkinson’s Disease Therapeutics Market Revenue Million Forecast, by Route of Administration 2019 & 2032
  6. Table 6: Global Parkinson’s Disease Therapeutics Market Volume K Tons Forecast, by Route of Administration 2019 & 2032
  7. Table 7: Global Parkinson’s Disease Therapeutics Market Revenue Million Forecast, by Patient 2019 & 2032
  8. Table 8: Global Parkinson’s Disease Therapeutics Market Volume K Tons Forecast, by Patient 2019 & 2032
  9. Table 9: Global Parkinson’s Disease Therapeutics Market Revenue Million Forecast, by Region 2019 & 2032
  10. Table 10: Global Parkinson’s Disease Therapeutics Market Volume K Tons Forecast, by Region 2019 & 2032
  11. Table 11: Global Parkinson’s Disease Therapeutics Market Revenue Million Forecast, by Drug Class 2019 & 2032
  12. Table 12: Global Parkinson’s Disease Therapeutics Market Volume K Tons Forecast, by Drug Class 2019 & 2032
  13. Table 13: Global Parkinson’s Disease Therapeutics Market Revenue Million Forecast, by Route of Administration 2019 & 2032
  14. Table 14: Global Parkinson’s Disease Therapeutics Market Volume K Tons Forecast, by Route of Administration 2019 & 2032
  15. Table 15: Global Parkinson’s Disease Therapeutics Market Revenue Million Forecast, by Patient 2019 & 2032
  16. Table 16: Global Parkinson’s Disease Therapeutics Market Volume K Tons Forecast, by Patient 2019 & 2032
  17. Table 17: Global Parkinson’s Disease Therapeutics Market Revenue Million Forecast, by Country 2019 & 2032
  18. Table 18: Global Parkinson’s Disease Therapeutics Market Volume K Tons Forecast, by Country 2019 & 2032
  19. Table 19: U.S. Parkinson’s Disease Therapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
  20. Table 20: U.S. Parkinson’s Disease Therapeutics Market Volume (K Tons) Forecast, by Application 2019 & 2032
  21. Table 21: Canada Parkinson’s Disease Therapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
  22. Table 22: Canada Parkinson’s Disease Therapeutics Market Volume (K Tons) Forecast, by Application 2019 & 2032
  23. Table 23: Global Parkinson’s Disease Therapeutics Market Revenue Million Forecast, by Drug Class 2019 & 2032
  24. Table 24: Global Parkinson’s Disease Therapeutics Market Volume K Tons Forecast, by Drug Class 2019 & 2032
  25. Table 25: Global Parkinson’s Disease Therapeutics Market Revenue Million Forecast, by Route of Administration 2019 & 2032
  26. Table 26: Global Parkinson’s Disease Therapeutics Market Volume K Tons Forecast, by Route of Administration 2019 & 2032
  27. Table 27: Global Parkinson’s Disease Therapeutics Market Revenue Million Forecast, by Patient 2019 & 2032
  28. Table 28: Global Parkinson’s Disease Therapeutics Market Volume K Tons Forecast, by Patient 2019 & 2032
  29. Table 29: Global Parkinson’s Disease Therapeutics Market Revenue Million Forecast, by Country 2019 & 2032
  30. Table 30: Global Parkinson’s Disease Therapeutics Market Volume K Tons Forecast, by Country 2019 & 2032
  31. Table 31: Germany Parkinson’s Disease Therapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
  32. Table 32: Germany Parkinson’s Disease Therapeutics Market Volume (K Tons) Forecast, by Application 2019 & 2032
  33. Table 33: UK Parkinson’s Disease Therapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
  34. Table 34: UK Parkinson’s Disease Therapeutics Market Volume (K Tons) Forecast, by Application 2019 & 2032
  35. Table 35: France Parkinson’s Disease Therapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
  36. Table 36: France Parkinson’s Disease Therapeutics Market Volume (K Tons) Forecast, by Application 2019 & 2032
  37. Table 37: Spain Parkinson’s Disease Therapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
  38. Table 38: Spain Parkinson’s Disease Therapeutics Market Volume (K Tons) Forecast, by Application 2019 & 2032
  39. Table 39: Italy Parkinson’s Disease Therapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
  40. Table 40: Italy Parkinson’s Disease Therapeutics Market Volume (K Tons) Forecast, by Application 2019 & 2032
  41. Table 41: Global Parkinson’s Disease Therapeutics Market Revenue Million Forecast, by Drug Class 2019 & 2032
  42. Table 42: Global Parkinson’s Disease Therapeutics Market Volume K Tons Forecast, by Drug Class 2019 & 2032
  43. Table 43: Global Parkinson’s Disease Therapeutics Market Revenue Million Forecast, by Route of Administration 2019 & 2032
  44. Table 44: Global Parkinson’s Disease Therapeutics Market Volume K Tons Forecast, by Route of Administration 2019 & 2032
  45. Table 45: Global Parkinson’s Disease Therapeutics Market Revenue Million Forecast, by Patient 2019 & 2032
  46. Table 46: Global Parkinson’s Disease Therapeutics Market Volume K Tons Forecast, by Patient 2019 & 2032
  47. Table 47: Global Parkinson’s Disease Therapeutics Market Revenue Million Forecast, by Country 2019 & 2032
  48. Table 48: Global Parkinson’s Disease Therapeutics Market Volume K Tons Forecast, by Country 2019 & 2032
  49. Table 49: Japan Parkinson’s Disease Therapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
  50. Table 50: Japan Parkinson’s Disease Therapeutics Market Volume (K Tons) Forecast, by Application 2019 & 2032
  51. Table 51: China Parkinson’s Disease Therapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
  52. Table 52: China Parkinson’s Disease Therapeutics Market Volume (K Tons) Forecast, by Application 2019 & 2032
  53. Table 53: India Parkinson’s Disease Therapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
  54. Table 54: India Parkinson’s Disease Therapeutics Market Volume (K Tons) Forecast, by Application 2019 & 2032
  55. Table 55: South Korea Parkinson’s Disease Therapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
  56. Table 56: South Korea Parkinson’s Disease Therapeutics Market Volume (K Tons) Forecast, by Application 2019 & 2032
  57. Table 57: Australia Parkinson’s Disease Therapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
  58. Table 58: Australia Parkinson’s Disease Therapeutics Market Volume (K Tons) Forecast, by Application 2019 & 2032
  59. Table 59: Global Parkinson’s Disease Therapeutics Market Revenue Million Forecast, by Drug Class 2019 & 2032
  60. Table 60: Global Parkinson’s Disease Therapeutics Market Volume K Tons Forecast, by Drug Class 2019 & 2032
  61. Table 61: Global Parkinson’s Disease Therapeutics Market Revenue Million Forecast, by Route of Administration 2019 & 2032
  62. Table 62: Global Parkinson’s Disease Therapeutics Market Volume K Tons Forecast, by Route of Administration 2019 & 2032
  63. Table 63: Global Parkinson’s Disease Therapeutics Market Revenue Million Forecast, by Patient 2019 & 2032
  64. Table 64: Global Parkinson’s Disease Therapeutics Market Volume K Tons Forecast, by Patient 2019 & 2032
  65. Table 65: Global Parkinson’s Disease Therapeutics Market Revenue Million Forecast, by Country 2019 & 2032
  66. Table 66: Global Parkinson’s Disease Therapeutics Market Volume K Tons Forecast, by Country 2019 & 2032
  67. Table 67: Brazil Parkinson’s Disease Therapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
  68. Table 68: Brazil Parkinson’s Disease Therapeutics Market Volume (K Tons) Forecast, by Application 2019 & 2032
  69. Table 69: Mexico Parkinson’s Disease Therapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
  70. Table 70: Mexico Parkinson’s Disease Therapeutics Market Volume (K Tons) Forecast, by Application 2019 & 2032
  71. Table 71: Argentina Parkinson’s Disease Therapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
  72. Table 72: Argentina Parkinson’s Disease Therapeutics Market Volume (K Tons) Forecast, by Application 2019 & 2032
  73. Table 73: Global Parkinson’s Disease Therapeutics Market Revenue Million Forecast, by Drug Class 2019 & 2032
  74. Table 74: Global Parkinson’s Disease Therapeutics Market Volume K Tons Forecast, by Drug Class 2019 & 2032
  75. Table 75: Global Parkinson’s Disease Therapeutics Market Revenue Million Forecast, by Route of Administration 2019 & 2032
  76. Table 76: Global Parkinson’s Disease Therapeutics Market Volume K Tons Forecast, by Route of Administration 2019 & 2032
  77. Table 77: Global Parkinson’s Disease Therapeutics Market Revenue Million Forecast, by Patient 2019 & 2032
  78. Table 78: Global Parkinson’s Disease Therapeutics Market Volume K Tons Forecast, by Patient 2019 & 2032
  79. Table 79: Global Parkinson’s Disease Therapeutics Market Revenue Million Forecast, by Country 2019 & 2032
  80. Table 80: Global Parkinson’s Disease Therapeutics Market Volume K Tons Forecast, by Country 2019 & 2032
  81. Table 81: South Africa Parkinson’s Disease Therapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
  82. Table 82: South Africa Parkinson’s Disease Therapeutics Market Volume (K Tons) Forecast, by Application 2019 & 2032
  83. Table 83: Saudi Arabia Parkinson’s Disease Therapeutics Market Revenue (Million) Forecast, by Application 2019 & 2032
  84. Table 84: Saudi Arabia Parkinson’s Disease Therapeutics Market Volume (K Tons) Forecast, by Application 2019 & 2032

STEP 1 - Identification of Relevant Samples Size from Population Database

Step Chart
bar chart
method chart

STEP 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

approach chart
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segemnts, product and application.

Note* : In applicable scenarios

STEP 3 - Data Sources

Primary Research

  • Web Analytics
  • Survey Reports
  • Research Institute
  • Latest Research Reports
  • Opinion Leaders

Secondary Research

  • Annual Reports
  • White Paper
  • Latest Press Release
  • Industry Association
  • Paid Database
  • Investor Presentations
approach chart

STEP 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally after gathering mix and scattered data from wide range of sources, data is triangull- ated and correlated to come up with estimated figures which are further validated through primary mediums, or industry experts, opinion leader.

Frequently Asked Questions

Get a Free Sample

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

Pricing

$4,850
Single User License:
  • Only one user can access this report at a time
  • Users are not allowed to take a print out of the report PDF
$5,350
Multi User License:
  • The report will be emailed to you in PDF format.
  • Allows 1-10 employees within your organisation to access the report.
$8,350
Corporate License:
  • Sharable and Printable among all employees of your organization
  • Excel Raw data with access to full quantitative & financial market insights
  • Customization at no additional cost within the scope of the report
  • Graphs and Charts can be used during presentation

Looking for a Custom Report?

We offer personalized report customization at no extra cost, including the option to purchase individual sections or country-specific reports. Plus, we provide special discounts for startups and universities. Get in touch with us today!

sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image
sponsor image

Tailored for you

  • In-depth Analysis Tailored to Specified Regions or Segments
  • Company Profiles Customized to User Preferences
  • Comprehensive Insights Focused on Specific Segments or Regions
  • Customized Evaluation of Competitive Landscape to Meet Your Needs
  • Tailored Customization to Address Other Specific Requirements
avatar

Director of Business Development

Sarah L

The insights provided in this report were spot-on and exactly what we needed to guide our strategic planning. The level of detail on industry trends and forecasts is unmatched. It saved us countless hours and gave us a significant advantage!"

Discover the Latest Market Insight Reports

Access in-depth insights on industries, companies, trends, and global markets. Our expertly curated reports provide the most relevant data and analysis in a condensed, easy-to-read format.

shop image 1

About Market Insights Report

Market Insights Reports offers comprehensive market research reports and analysis, giving businesses important information about their clients, rivals, and sector to help them make well-informed decisions on operations, marketing, and business strategy. We offer a variety of services in addition to market research, data analysis, and strategy planning. In order to find opportunities and learn more about our competitors and the industry at large, we employ competitive analysis. To identify areas for development, we also evaluate our performance against that of our rivals. We can determine the places at which we can offer our clients the most value by performing value chain analysis.

Additionally, clients receive a thorough overview of their industry business environment. We can find trends that help us forecast future possibilities and threats by examining global macroeconomic dynamics and consumer behavior patterns. By analyzing their features and advantages, contrasting them with comparable items on the market, and evaluating both their quantitative and qualitative performance, we comprehensively evaluate our clients' products. This allows us to assist customers in determining how their goods compare to those of their rivals and in creating successful marketing plans. Our group has been successful in gaining a thorough grasp of our clients' requirements and offering them creative solutions. We currently provide services to more than 50 nations in Europe, the Middle East, Africa, Latin America, Asia Pacific, and North America. Because of our global reach, we have been able to establish trusting bonds with our partners and clients in various nations, improving customer service and forging a more cohesive worldwide presence.

+1 2315155523

sales@marketinsights.report

  • Home
  • About Us
  • Industries
    • Aerospace & Defense
    • Automotive
    • Semiconductors & Electronics
    • Agriculture
    • Chemicals & Materials
    • Construction
    • Consumer Goods and Services
    • Energy & Power
    • Food & Beverage
    • Healthcare
    • Media & Technology
    • Industrial Machinery
    • Packaging
    • Professional Services
    • Animal Health & Nutrition
  • Services
  • Contact
Main Logo
  • Home
  • About Us
  • Industries
    • Aerospace & Defense
    • Automotive
    • Semiconductors & Electronics
    • Agriculture
    • Chemicals & Materials
    • Construction
    • Consumer Goods and Services
    • Energy & Power
    • Food & Beverage
    • Healthcare
    • Media & Technology
    • Industrial Machinery
    • Packaging
    • Professional Services
    • Animal Health & Nutrition
  • Services
  • Contact
sales@marketinsights.report

Business Address

Head Office

Office no. A 5010, fifth floor, Solitaire Business Hub, Near Phoenix mall, Pune, Maharashtra 411014

Contact Information

Craig Francis

Business Development Head

+1 2315155523

sales@marketinsights.report

Extra Links

AboutContactsTestimonials
ServicesCareer

Subscribe

Get the latest updates and offers.

PackagingAutomotiveHealthcareAgricultureConstructionEnergy & PowerFood & BeverageMedia & TechnologyAerospace & DefenseIndustrial MachineryChemicals & MaterialsProfessional ServicesAnimal Health & NutritionConsumer Goods and ServicesSemiconductors & Electronics

© 2025 AMA Research. All rights reserved

Testimonials
Privacy Policy
Terms and Conditions
FAQ

Related Reports

See the similar reports

report thumbnailU.S. Clinical Nutrition Market

U.S. Clinical Nutrition Market Strategic Market Roadmap: Analysis and Forecasts 2025-2033

report thumbnailTelerehabilitation Market

Telerehabilitation Market Unlocking Growth Potential: Analysis and Forecasts 2025-2033

report thumbnailAbsorbable Nasal Implant Devices Market

Absorbable Nasal Implant Devices Market Soars to 581.6 Million, witnessing a CAGR of 7 during the forecast period 2025-2033

report thumbnailLive cell encapsulation Market

Live cell encapsulation Market Dynamics and Forecasts: 2025-2033 Strategic Insights

report thumbnailNasal Spray Market

Nasal Spray Market Strategic Roadmap: Analysis and Forecasts 2025-2033

report thumbnailGene Vector Market

Gene Vector Market Decade Long Trends, Analysis and Forecast 2025-2033

report thumbnailEndocrine Testing Market

Endocrine Testing Market 2025 Trends and Forecasts 2033: Analyzing Growth Opportunities

report thumbnailPulmonary Function Testing Systems Market

Pulmonary Function Testing Systems Market Report Probes the 2 billion Size, Share, Growth Report and Future Analysis by 2033

report thumbnailAutomated Immunoassay Analyzers Market

Automated Immunoassay Analyzers Market Growth Opportunities and Market Forecast 2025-2033: A Strategic Analysis

report thumbnailDental Digital X-ray Market

Dental Digital X-ray Market Insightful Analysis: Trends, Competitor Dynamics, and Opportunities 2025-2033

report thumbnailPharmaceutical Gelatin Market

Pharmaceutical Gelatin Market 2025 to Grow at 5.6 CAGR with 1.1 billion Market Size: Analysis and Forecasts 2033

report thumbnailLung Cancer Treatment Market

Lung Cancer Treatment Market Unlocking Growth Potential: 2025-2033 Analysis and Forecasts

report thumbnailECG Stress Test Market

ECG Stress Test Market 2025 to Grow at 8.1 CAGR with 2.3 Billion Market Size: Analysis and Forecasts 2033

report thumbnailHealthcare Payer Services Market

Healthcare Payer Services Market Report 2025: Growth Driven by Government Incentives and Partnerships

report thumbnailNon-animal Alternative Testing Market

Non-animal Alternative Testing Market Unlocking Growth Potential: Analysis and Forecasts 2025-2033

report thumbnailDegenerative Disc Disease Treatment Market

Degenerative Disc Disease Treatment Market Charting Growth Trajectories 2025-2033: Strategic Insights and Forecasts

report thumbnailHealthcare Assistive Robot Market

Healthcare Assistive Robot Market 2025-2033 Trends: Unveiling Growth Opportunities and Competitor Dynamics

report thumbnailUrinary Retention Therapeutics Market

Urinary Retention Therapeutics Market 2025 Market Trends and 2033 Forecasts: Exploring Growth Potential

report thumbnailSurgical Rasps Market

Surgical Rasps Market Strategic Insights: Analysis 2025 and Forecasts 2033

report thumbnailCarrier Screening Market

Carrier Screening Market 2025 Market Trends and 2033 Forecasts: Exploring Growth Potential